{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:51:25Z","timestamp":1781848285571,"version":"3.54.5"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"47","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,14]]},"DOI":"10.1093\/eurheartj\/ehac614","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T11:06:27Z","timestamp":1666782387000},"page":"4943-4945","source":"Crossref","is-referenced-by-count":8,"title":["Drug abuse and risk of atrial fibrillation: a neglected association"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4619-9062","authenticated-orcid":false,"given":"Monika","family":"Gawa\u0142ko","sequence":"first","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht , Universiteitssingel 50, 6229 ER, Maastricht , The Netherlands"},{"name":"1st Department of Cardiology, Medical University of Warsaw , Warsaw , Poland"},{"name":"Institute of Pharmacology, West German Heart and Vascular Centre, University Duisburg-Essen , Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3803-8429","authenticated-orcid":false,"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[{"name":"Centre for Heart Rhythm Disorders, University of Adelaide , Adelaide , Australia"},{"name":"Department of Cardiology, Royal Adelaide Hospital , Adelaide , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"2022121408320205400_ehac614-B1","author":"United Nations"},{"key":"2022121408320205400_ehac614-B2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010273","article-title":"Stimulant drugs of abuse and cardiac arrhythmias","volume":"15","author":"Dominic","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022121408320205400_ehac614-B3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2022121408320205400_ehac614-B4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jamainternmed.2015.1045","article-title":"Association between opioid use and atrial fibrillation: the reasons for geographic and racial differences in stroke (REGARDS) study","volume":"175","author":"Qureshi","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2022121408320205400_ehac614-B5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.amjcard.2018.03.015","article-title":"Relation of cannabis use and atrial fibrillation among patients hospitalized for heart failure","volume":"122","author":"Adegbala","year":"2018","journal-title":"Am J Cardiol"},{"key":"2022121408320205400_ehac614-B6","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1093\/eurheartj\/ehac558","article-title":"Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation","volume":"43","author":"Lin","year":"2022","journal-title":"Eur Heart J"},{"key":"2022121408320205400_ehac614-B7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/heartjnl-2019-315327","article-title":"Lifestyle modifications for treatment of atrial fibrillation","volume":"106","author":"Middeldorp","year":"2020","journal-title":"Heart"},{"key":"2022121408320205400_ehac614-B8","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jacep.2021.05.013","article-title":"Risk thresholds for total and beverage-specific alcohol consumption and incident atrial fibrillation","volume":"7","author":"Tu","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2022121408320205400_ehac614-B9","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/eurheartj\/ehaa953","article-title":"Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes","volume":"42","author":"Csengeri","year":"2021","journal-title":"Eur Heart J"},{"key":"2022121408320205400_ehac614-B10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/2047487318780435","article-title":"Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies","volume":"25","author":"Aune","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2022121408320205400_ehac614-B11","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/JOM.0000000000000565","article-title":"Environmental tobacco smoke and atrial fibrillation: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study","volume":"57","author":"O'Neal","year":"2015","journal-title":"J Occup Environ Med"},{"key":"2022121408320205400_ehac614-B12","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jacc.2019.07.060","article-title":"Childhood tobacco smoke exposure and risk of atrial fibrillation in adulthood","volume":"74","author":"Groh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022121408320205400_ehac614-B13","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"2022121408320205400_ehac614-B14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.hrtlng.2020.12.009","article-title":"National rates and trends of tobacco and substance use disorders among atrial fibrillation hospitalizations","volume":"50","author":"Doshi","year":"2021","journal-title":"Heart Lung"},{"key":"2022121408320205400_ehac614-B15","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-induced arrhythmias: a scientific statement from the American Heart Association","volume":"142","author":"Tisdale","year":"2020","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/47\/4943\/47847585\/ehac614.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/47\/4943\/47847585\/ehac614.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T02:27:07Z","timestamp":1678242427000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/47\/4943\/6774408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":15,"journal-issue":{"issue":"47","published-online":{"date-parts":[[2022,10,26]]},"published-print":{"date-parts":[[2022,12,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac614","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,14]]},"published":{"date-parts":[[2022,10,26]]}}}